liposomal botulinum toxin a
Biologicalexperimental
Clinical trial activity
5 trials · 4 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
4
Phase 3
2
Phase 4
0
Earliest trial started May 1, 2010 (NCT01167257)
Timeline
Indications
Mechanism of action
- AcetylcholinesteraseINHIBITOR
ACHE inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- liposomal botulinum toxin a
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05321979 | Phase 3 | Feb 7, 2022 | Medy-Tox |
| NCT05059587 | Phase 3 | Aug 30, 2021 | Medy-Tox |
| NCT03547141 | Phase 1 | Apr 16, 2018 | Catholic University of Korea, Medy-Tox |
| NCT02247557 | Phase 2 | Sep 1, 2014 | Tzu Chi University |
| NCT01167257 | Phase 2 | May 1, 2010 | Chang Gung University, Tzu Chi University |
Showing 5 of 5 trials
Page 1 / 1
Organizations
Research & Development (4)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Medy-Tox | For profit | 3 | 3 | 2 | 2018 |
| Tzu Chi University | Academic/Hospital | 2 | 2 | 1 | 2010 |
| Catholic University of Korea | Academic/Hospital | 1 | 0 | 1 | 2018 |
| Chang Gung University | Academic/Hospital | 1 | 0 | 1 | 2010 |
4 organizations
Page 1 / 1